Ara
Toplam kayıt 9, listelenen: 1-9
Fecal calprotectin levels in Helicobacter pylori gastritis in children
(2020)
Background. Fecal calprotectin is an important inflammatory marker in intestinal diseases and is not routinely used in the upper gastrointestinal system disorders. The aim of this study was to show whether there is a ...
The Frequency of Lysosomal Acid Lipase Deficiency in Children With Unexplained Liver Disease
(2019)
Objectives: Evidence suggests that lysosomal acid lipase deficiency (LAL-D) is often underdiagnosed because symptoms may be nonspecific. We aimed to investigate the prevalence of LAL-D in children with unexplained liver ...
Can platelet count/spleen diameter ratio be used for cirrhotic children to predict esophageal varices?
(2016)
AIM
To determine the laboratory and radiologic parameters, including the platelet count (PC)-to-spleen diameter (SD) ratio as a non-invasive marker that may predict the presence of esophageal varices (EV) in children ...
The safety and efficacy of ERCP in the pediatric population with standard scopes: Does size really matter?
(2016)
Experience with endoscopic retrograde cholangiopancreatography in the pediatric population is limited. The aim of this study was to evaluate the outcomes of ERCP in the pediatric population performed by adult gastroenterologists ...
A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy
(2018)
Background/Aims: We evaluated our 16-year single-center experience of pediatric post-transplant lymphoproliferative disorder (PTLD) cases who underwent liver transplantation between 2001 and 2017.
Materials and Methods: ...
Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency
(2018)
BACKGROUND & AIMS: Congenital diarrheal disorders are rare inherited intestinal disorders characterized by intractable, sometimes life-threatening, diarrhea and nutrient malabsorption; some have been associated with mutations ...
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
(2021)
CHAPLE disease is a lethal syndrome caused by genetic loss of the complement regulatory protein CD55. Lenardo, Ozen and their colleagues report that blockade of C5 complement activation in a small cohort of pediatric ...